Skip to content

The Effect of Pulsatile and Non-pulsatile Perfusion Flow on Renal Function during Coronary Artery Bypass Grafting Surgery in Patients with Left Ventricular Dysfunction

Comparison of the Effect of Pulsatile and Non-pulsatile Perfusion Flow on Renal Function during Coronary Artery Bypass Grafting Surgery in Patients with Left Ventricular Dysfunction

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190218042749N1
Enrollment
80
Registered
2019-07-15
Start date
2018-01-21
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who have Coronary Artery Disease candidate of CABG with left ventricular dysfunction. Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris

Interventions

Intervention 1: Control group: CABG candid patients who suffer from left ventricular dysfunction and received non-pulsatile flow during the surgery via Pump machine. Intervention 2: Intervention grou

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients referring to Operation room for Elective CABG in dependent hospitals to Shiraz University of Medical Sciences participation satisfaction in attending the project left Ventricular dysfunction Bypass Coronary Grafting Surgery enjoying EF pulsatile lower than 40 percent( based on Suggestions from American Cardiography Association) equivalent to severe left ventricular dysfunction Ages from 40 to 75

Exclusion criteria

Exclusion criteria: lack of patient's tendency to continue the study simultaneous surgery of Valve and Coronary Anesthesia risk more than 3 Sepsis Renal dysfunction (Cr>1.5) Redo Liver Dysfunction Records of brain stroke Concurrent autoimmune diseases Records of immunosuppressive drugs, Chemotherapy or radiotherapy emergency patients

Design outcomes

Primary

MeasureTime frame
Renal parameter UO24h. Timepoint: Before bypass surgery, During bypass surgery, three days after bypass surgery,. Method of measurement: Laboratory variables were sent to the laboratory and got analyzed with the related devices. 24-hour urine volume after the surgery was measured by the ICU nurses.;Renal parameter BUN. Timepoint: Before bypass surgery, During bypass surgery, three days after bypass surgery,. Method of measurement: Laboratory variables were sent to the laboratory and got analyzed with the related devices. 24-hour urine volume after the surgery was measured by the ICU nurses.;Renal parameter GFR. Timepoint: Before bypass surgery, During bypass surgery, three days after bypass surgery,. Method of measurement: Laboratory variables were sent to the laboratory and got analyzed with the related devices. 24-hour urine volume after the surgery was measured by the ICU nurses.;Renal parameter Cr. Timepoint: Before bypass surgery, During bypass surgery, three days after bypass surgery,. Method of measurement: Laboratory variables were sent to the laboratory and got analyzed with the related devices. 24-hour urine volume after the surgery was measured by the ICU nurses.

Secondary

MeasureTime frame
BMI. Timepoint: Before bypass surgery. Method of measurement: Based on Patient's File.;Bleeding rate. Timepoint: three days after bypass surgery in ICU. Method of measurement: Bleeding rate was determined based on the scaled chest bottle tube.;Gender. Timepoint: Before bypass surgery. Method of measurement: Based on Patient's File.;Age. Timepoint: Before bypass surgery. Method of measurement: Based on Patient's File.;EF. Timepoint: Before bypass surgery. Method of measurement: Based on Patient's File.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Zamani Jahromi

Shiraz University of Medical Sciences

marziehzamani@jums.ac.ir+98 71 5426 7727

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026